926P Real-world data in the era of immune checkpoint inhibitors (ICIs): Cetuximab-containing first-line therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma
Saved in:
| Published in | Annals of oncology Vol. 31; p. S667 |
|---|---|
| Main Authors | , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Elsevier Ltd
01.09.2020
|
| Online Access | Get full text |
Cover
Loading…
| Author | Lien, M-Y. Tsai, M-H. Hsieh, C-H. Hsieh, C-Y. Wang, T-H. Hua, C-H. Tang, C-H. Fu-Ming, C. |
|---|---|
| Author_xml | – sequence: 1 givenname: C. surname: Fu-Ming fullname: Fu-Ming, C. organization: Internal Medicine, China Medical University Hospital, Taichung, Taiwan – sequence: 2 givenname: C-Y. surname: Hsieh fullname: Hsieh, C-Y. organization: Internal Medicine, China Medical University Hospital, Taichung, Taiwan – sequence: 3 givenname: T-H. surname: Wang fullname: Wang, T-H. organization: Radiation Oncology, China Medical University Hospital, Taichung, Taiwan – sequence: 4 givenname: M-H. surname: Tsai fullname: Tsai, M-H. organization: Otolaryngology, China Medical University Hospital, Taichung, Taiwan – sequence: 5 givenname: C-H. surname: Hua fullname: Hua, C-H. organization: Otorhinolaryngology, China Medical University Hospital, Taichung, Taiwan – sequence: 6 givenname: C-H. surname: Tang fullname: Tang, C-H. organization: China Medical University, Taichung, Taiwan – sequence: 7 givenname: C-H. surname: Hsieh fullname: Hsieh, C-H. organization: Division of Hematology-Oncology, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan – sequence: 8 givenname: M-Y. surname: Lien fullname: Lien, M-Y. organization: Internal Medicine, China Medical University Hospital, Taichung, Taiwan |
| BookMark | eNqFUcFu1DAQtVArsW35BKQ5wiHbseNkEy4IrQqsVAlUlbM1cRziJbEX26H09_gyHC13Th6_mfdmnt4Vu3DeGcZec9xy5PXtcUsuQ3orUOAWm4xK_oJteFW3RZPrC7bBVpTFrirlS3YV4xER61a0G_anFfVXeDA0FU8-TD30lAisgzQaMIHAD2DneXEG9Gj0j5O3LuX-aDubfIjw5rA_xLfvYG_S8tvO1BXau0TWWfcdBhtiKiab2Vkv0Ol5lT5RssalCE82jRCMXkLIfyDX3_oAs0kUU57RMBrqVxhcXg3x50KzXyJoM02gKWjr_Ew37HKgKZpX_95r9u3j3eP-c3H_5dNh_-G-0Fy2vBDY9ZXcVTvipmpRShQSqe66jnTXICdeyoqwrHrUQu90LQl1Q0IM7dDIHstrVp11dfAxBjOoU8iGw7PiqNYg1FGdg1BrEAobtQaRee_PPJOP-2VNUFFn_9r0NntPqvf2Pwp_Ad7umOo |
| ContentType | Journal Article |
| Copyright | 2020 European Society for Medical Oncology |
| Copyright_xml | – notice: 2020 European Society for Medical Oncology |
| DBID | AAYXX CITATION |
| DOI | 10.1016/j.annonc.2020.08.1041 |
| DatabaseName | CrossRef |
| DatabaseTitle | CrossRef |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1569-8041 |
| EndPage | S667 |
| ExternalDocumentID | 10_1016_j_annonc_2020_08_1041 S0923753420410373 |
| GroupedDBID | --- -E4 .2P .86 .I3 .XZ .ZR 08P 0R~ 0U7 1TH 23M 2WC 4.4 482 48X 53G 5GY 5VS 5WA 6.Y 6J9 70D AABJS AABMN AAEDW AAESY AAIAV AAIYJ AAJKP AAJQQ AAKAS AAKUH AAMVS AAOGV AAPNW AAUQX AAXUO ABEUO ABIXL ABJNI ABKDP ABLJU ABNKS ABOCM ABQLI ABQTQ ABSAR ABSMQ ABVKL ABZBJ ACGFO ACGFS ACIMA ACMRT ACPQN ACPRK ACUFI ACUTO ADBBV ADEIU ADEYI ADHKW ADHZD ADJQC ADOCK ADORX ADQLU ADRIX ADRTK ADYVW ADZCM ADZXQ AEGPL AEGXH AEJOX AEKPW AEKSI AEMDU AENEX AENZO AEPUE AEWNT AFIYH AFOFC AFXEN AGINJ AGKEF AGKRT AGSYK AHMBA AHXPO AIAGR AIJHB AIKOY AITUG ALMA_UNASSIGNED_HOLDINGS ALUQC AMRAJ APIBT APWMN AQKUS ASMCH ASPBG ATTQO AVWKF AWCFO AXUDD AZFZN AZQFJ BAWUL BAYMD BEYMZ BGNMA BGYMP BHONS BTRTY BVRKM BZKNY C1A CAG CASEJ CDBKE CKLRP COF CS3 CZ4 DAKXR DIK DILTD DL5 DPORF DPPUQ D~K E3Z EBS EE~ EJD EX3 F9B FDB FEDTE GJXCC GX1 H5~ HAR HVGLF HW0 HZ~ I09 IH2 IHE IOX J21 KAQDR KC5 KDC KOM KOP KQ8 KSI KSN LAK M-Z M41 M49 M4Y MBLQV MHKGH N9A NCXOZ NGC NOYVH NTWIH NU- NU0 NVLIB O9- OAWHX ODMLO OJQWA OK1 OVD P2P P6G PAFKI PB- PEELM PQQKQ Q1. Q5Y QBD R44 RD5 RNI ROL ROX ROZ RPX RW1 RXO RZC RZE RZF RZO SDH TCURE TEORI TJX TMA TR2 U2A W8F WOQ WOW X7H YAYTL YFH YKOAZ ZKX ZXP ~91 0SF AALRI AAYXX ADVLN AEHUL AFETI AFJKZ AFSHK AKRWK CITATION H13 |
| ID | FETCH-LOGICAL-c1491-20bd54757a1e590440240a6bbbacb801a1345a035d0c2c7c64a0c8a22f9f84d03 |
| IEDL.DBID | ABVKL |
| ISSN | 0923-7534 |
| IngestDate | Thu Sep 26 18:50:03 EDT 2024 Fri Feb 23 02:47:14 EST 2024 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c1491-20bd54757a1e590440240a6bbbacb801a1345a035d0c2c7c64a0c8a22f9f84d03 |
| OpenAccessLink | http://www.annalsofoncology.org/article/S0923753420410373/pdf |
| ParticipantIDs | crossref_primary_10_1016_j_annonc_2020_08_1041 elsevier_sciencedirect_doi_10_1016_j_annonc_2020_08_1041 |
| PublicationCentury | 2000 |
| PublicationDate | September 2020 2020-09-00 |
| PublicationDateYYYYMMDD | 2020-09-01 |
| PublicationDate_xml | – month: 09 year: 2020 text: September 2020 |
| PublicationDecade | 2020 |
| PublicationTitle | Annals of oncology |
| PublicationYear | 2020 |
| Publisher | Elsevier Ltd |
| Publisher_xml | – name: Elsevier Ltd |
| SSID | ssj0006929 |
| Score | 2.381879 |
| SourceID | crossref elsevier |
| SourceType | Aggregation Database Publisher |
| StartPage | S667 |
| Title | 926P Real-world data in the era of immune checkpoint inhibitors (ICIs): Cetuximab-containing first-line therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma |
| URI | https://dx.doi.org/10.1016/j.annonc.2020.08.1041 |
| Volume | 31 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwELXKVkJcEJ-itFRz4AAHN46TOElvZUXVpRQhoKi3yJ44qos2u-xmpfL3-ss6s8nyISEOHOPISeRxZp7teW-EeEko3udKo8QSE5k2xkiHTS49oZMya4zHNUPu7IM5OU_fXWQXW2K84cJwWuXg-3ufvvbWQ0s0jGY0DyH6rAibENhOtUqZ7JbcEduaj5lGYvvozdfT9z8dsil1L7mnE8kdfhF5oqsD29Iym7UMtWItT1qdxH8PUb-FneMH4v6AF-Go_6SHYsu3j8Tds-FE_LG4KbX5CJ8I7sm1-ClwyieEFgjYgV9YmDUQmAPigcyD3-az0HZ0_zK4wIV24NVkPFm-PoSx71bXYWqd5Oz1vm4ENIHAoWQkCj1R6wc_etBiXQJv4sKCd-xZ4wlsW0ezBUx9Z5mnFBDI09fcDC29GpbfV5Z3GoBPCwC5ilE7m9on4vz47ZfxiRzqMkik9VRMP5arszTPchv7rOSa1QQLrHHOWXQU8WycpJlVSVYr1JijSa3CwmrdlE2R1ip5KkY06P6ZAIUUOWtvMLY6zTFzaE1RoCbIn2nyRjviYGOKat7Lb1SbvLSrqrddxbarVFGx7XZEsTFY9cc8qihE_Lvr8__vuivu8WWfe7YnRt1i5V8QWOnc_jAZ9wmuT05vAQkn6vY |
| link.rule.ids | 315,786,790,27600,27955,27956,45696 |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKKwEXxFMt5TEHDnBw13ESJ-FWVlS7dLdC0KLeInviCBdtdrubleDv8cuY2WR5SIgDV1tOIo8z89me7xshXhCK95nSKLHAWCa1MdJhnUlP6KRIa-Nxw5CbnpnRRfLuMr3cEcMtF4bTKnvf3_n0jbfuWwb9bA4WIQw-KsImBLYTrRImu8U3xB6hgYKW-d7xm0-nk58O2RS6k9zTseQBv4g8g6sj29A2m7UMtWItT9qdRH8PUb-FnZO74k6PF-G4-6R7Ysc398XNaX8j_kB8L7R5Dx8I7smN-ClwyieEBgjYgV9amNcQmAPigcyDXxbz0LTU_zm4wIV24OV4OF69eg1D366_hpl1krPXu7oRUAcCh5KRKHRErW_86F6LdQV8iAtLPrFnjSewTTWYL2HmW8s8pYBAnr7iZmjo1bC6Xls-aQC-LQDkKkbNfGYfiouTt-fDkezrMkik_VREP5ar0iRLMxv5tOCa1QQLrHHOWXQU8WwUJ6lVcVop1JihSazC3GpdF3WeVCp-JHZp0v2-AIUUOStvMLI6yTB1aE2eoybIn2ryRgfiaGuKctHJb5TbvLSrsrNdybYrVV6y7Q5EvjVY-cc6KilE_Hvo4_8f-lzcGp1PJ-VkfHZ6KG5zV5eH9kTstsu1f0rApXXP-oX5A8o27PY |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=926P+Real-world+data+in+the+era+of+immune+checkpoint+inhibitors+%28ICIs%29%3A+Cetuximab-containing+first-line+therapy+in+patients+with+recurrent+and%2For+metastatic+head+and+neck+squamous+cell+carcinoma&rft.jtitle=Annals+of+oncology&rft.au=Fu-Ming%2C+C.&rft.au=Hsieh%2C+C-Y.&rft.au=Wang%2C+T-H.&rft.au=Tsai%2C+M-H.&rft.date=2020-09-01&rft.issn=0923-7534&rft.volume=31&rft.spage=S667&rft_id=info:doi/10.1016%2Fj.annonc.2020.08.1041&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_annonc_2020_08_1041 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0923-7534&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0923-7534&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0923-7534&client=summon |